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icense.Abstract Background: GISTs are considered the commonest mesenchymal neoplasms of the GIT
originating from the gastrointestinal tract, mesentery, omentum, or retroperitoneum. They arise within
the gutmusculosa having exophytic growth pattern. They characteristically have hemorrhage, necrosis,
or cyst formation that appears as focal areas of low attenuation on computed tomographic images.
With multidetector CT (MDCT) capabilities, the exact origin of the GIST can be easily conﬁrmed to
differentiate it from other mesenchymal origin tumors.
Materials andmethods: Retrospective search forGIST cases in the digital archives of our institute, dur-
ing a 15 months duration (April 2010 to July 2011). Workstation reviewing of their imaging features.
Results: This study included 24 pathologically proved GISTs (12 gastric, 8 small intestinal, two colo-
nic, one mesenteric and one anorectal) demonstrating the radiologic features of GISTs depending on
tumor size and organ of origin.
Conclusion: MDCT with its multiplanar capabilities and isotropic z-axis resolution allows the radiol-
ogist to examine the detailed relation of themass to the surrounding bowel wall, vessels and other struc-
tures. It also helps to map the vascular pedicle in cases of hypervascular GIST’s, which may be crucial
for trans-catheter embolization in cases presenting with acute gastrointestinal bleeding.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.7435706 ; fax: +20 34869754.
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Gastrointestinal stromal tumors (GISTs) comprise a group of
mesenchymal neoplasms that are distinct from true smooth
muscle and neural tumors and considered the commonest mes-
enchymal neoplasms of the gastrointestinal tract. (1)
GISTs, leiomyomas, and leiomyosarcomas are distinctly
different neoplasms that arise with variable frequency through-
out the gastrointestinal tract. GISTs are the most common and
may occur from the esophagus to the anus. They may also
occur primarily in the omentum, mesentery, and retroperito-
neum. The esophagus is the only site where leiomyomas
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leiomyomas; 25% are GISTs) (1,2).
In the stomach, small intestine, colon, and anorectum,
GISTs account for almost all mesenchymal tumors, as leio-
myomas and leiomyosarcomas in these sites are very rare (2).
Previously, it was referred to these tumors as smooth mus-
cle tumors, leiomyomas and leiomyosarcomas because these
tumors were believed to originate from the smooth muscle
layers of the wall of the gastrointestinal tract, which led to pro-
found diagnostic confusion and is indicative of the diverse
radiologic and histologic manifestations of mesenchymal neo-
plasms (2).
The best deﬁning feature of GISTs is the expression of KIT
(CD117), a tyrosine kinase growth factor receptor. Immunore-
activity for KIT distinguishes GISTs from true leiomyomas,
leiomyosarcomas and schwannomas. Pharmacologically tar-
geting this receptor with a KIT tyrosine kinase inhibitor
(STI-571, Imatinib) has been shown to be of clinical utility
in treating patients with GISTs (3).
The clinical manifestation of GISTs is highly variable with
wide spectrum of radiologic appearances. For small benign
looking GISTs, they are discovered incidentally during radio-
logic evaluation or surgery for another condition. In contrast,
other patients present with profound symptoms that reﬂect
large or highly aggressive GISTs that invade adjacent organs
and metastasize (4,5).
2. Materials and methods
This article summarizes the current literature and our recent
experience with the help of MDCT in the diagnosis of 24 cases
of GIST (12 gastric, 8 small intestinal, two colonic, one mesen-
teric and one anorectal).
Data was collected from the digital archives of our institute,
during a 15 months duration (April 2010 to July 2011).
The scans were performed using a 16-slice MDCT machine
(Siemens, Erlangen, Germany). The patients were prepared
with neutral oral contrast (iso-osmotic mannitol) except for
three patients that ingested positive oral contrast prior to the
examination. The study included a non-contrast series, fol-
lowed by a dual-phase scan after automatic IV injection of
120 ml non-ionic contrast (Ultravist, Scherring). The phases
were: Enteric phase at 45 s following the start of contrast injec-
tion; portal phase at 70 s. Although this may constitute an
added radiation load, we believe it adds additional data in
cases of GIT bleeding to detect the source of hemorrhage.
The clinical, pathologic, and radiologic spectrum of GISTs
throughout the gastrointestinal tract are presented and sum-
marized in view of these cases.
3. Clinical features
The exact prevalence of GISTs is difﬁcult to determine.
Miettinen and Lasota (6) estimated the frequency of GISTs
as 10–20 cases per million persons. No association between
geographic location, ethnicity, race, or occupation has been
established. Most individuals are over 50 years of age at the
time of presentation, and GISTs are rarely seen in patients
younger than 40 years of age (7,8).
Although some studies in the literature show a slight male
predominance, others show no gender predilection (7).Patients with neuroﬁbromatosis type 1 (NF1) have an in-
creased prevalence of GISTs. Classically, patients with NF1
have multiple small intestinal GISTs (9,10). GISTs are likely
a feature of the Carney triad, which is a rare condition refer-
ring to the association of an epithelioid leiomyosarcoma with
paraganglioma and pulmonary chondroma (11).
Presenting signs and symptoms depend on the size and ana-
tomic location of the tumor. GISTs most frequently occur in
the stomach (60–65% of cases), followed by the small intestine
(30–35%), anorectum (7%), colon, and esophagus (12).
The most common clinical manifestation for symptomatic
GISTs is gastrointestinal bleeding from mucosal ulceration
(13). Patients may present with hematemesis, melena, hemato-
chezia, or signs and symptoms of anemia caused by occult
bleeding. Other signs and symptoms include nausea, vomiting,
abdominal pain, weight loss, abdominal distention, and intes-
tinal obstruction.
Occasionally, small asymptomatic GISTs are discovered
incidentally during a radiologic evaluation or surgical proce-
dure performed for other reasons. Asymptomatic anorectal tu-
mors may be discovered as a palpable mass during routine
digital rectal examination (14).
4. Pathologic features (15,16)
GISTs range in size from several millimeters to greater than
30 cm (15). They are typically well-circumscribed masses that
compress adjacent tissue and lack a true capsule. Cut sections
of specimens have a pink, tan, or gray surface. Focal areas of
hemorrhage, cystic degeneration, and necrosis may occur, par-
ticularly in large lesions.
GISTs of the hollow gastrointestinal tract most commonly
involve the muscularis propria of the intestinal wall. Mesen-
chymal tumors that involve the muscularis mucosae most fre-
quently arise in the colon and occur as polyps. Such tumors are
thought to uniformly represent true leiomyomas (16).
Because GISTs usually involve the outer muscular layer,
they have a propensity for exophytic growth. Therefore, the
most common appearance is that of a mass arising from the
intestinal wall and projecting into the abdominal cavity (16).
Often, a component of the tumor distends to the mucosal sur-
face of the involved segment of intestine. Mucosal ulceration is
seen on the luminal surface of the tumor in up to 50% of cases
(15).
Cavities form from extensive hemorrhage or necrosis and
may communicate with the intestinal lumen. Aneurysmal dila-
tation of the involved segment of the colon is an uncommon
feature of colonic GISTs (15).
Small intestinal GISTs may have a more aggressive course
compared with that of gastric GISTs of the same size. There-
fore, the size threshold for estimating recurrent or metastatic
risk in small intestinal GISTs may be smaller than that for
gastric GISTs. The majority of esophageal, colonic, and ano-
rectal GISTs are malignant (16).
5. Radiologic features
5.1. Stomach
Considered the commonest site for origin of GISTs which
make up 2–3% of all gastric tumors. In our series of 24 GISTs,
Figure 1 Male 48 years with abdominal distension (A) axial, and (B) sagittal contrast enhanced CT revealed large gastric GIST
originating from lesser curvature with exophytic necrotic component reaching down to the pelvic cavity through right side of abdominal
cavity. The soft tissue component with heterogeneous enhancement encasing gastric contour and encroaching upon gastric lumen.
Figure 2 Female 33 years presented with occult blood in the stool revealed small mural based enhancing gastric GIST (star) from
anterior wall of gastric fundus which is mildly thickened, bulging within the lumen and showing homogenous contrast enhancement. No
associated exophytic component.
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(17%) was conﬁned to the cardia and fundus of the stomach,
six (50%) were in the body, and four (33%) were in the
antrum.
Regarding the size, the tumors ranged from 3.4 to 22 cm
(mean is 11.3 cm) in maximal dimension with the largest GIST
mass of all our cases reached down to the pelvic cavity (Fig. 1).
In our study, no correlation between radiologic appearance
and malignant potential could be established with regard to
the size, degree of necrosis, hemorrhage, cyst formation, or
contrast enhancement on computed tomographic (CT) images.
CT showed an intramural component in three cases of 12
cases gastric GIST (25%) that we reviewed (Fig. 2).
Extragastric extension was present in 75% of cases. Exten-
sion may occur in the direction of gastrohepatic ligament
(Fig. 3), into the gastrosplenic ligament (Fig. 4), or posteriorly
into the lesser sac.
In many cases, the bulk of the tumor was in an extragastric
location, which makes it difﬁcult to appreciate the origin of the
tumor from the gastric wall on CT images. Reviewing all
images on the work station in the three planes as well as the
oblique direction helps in assessing the origin of the lesion
and the direction of growth (17,18).
The tumor may be attached to the gastric wall by a thin
pedicle. Careful evaluation of the gastric wall in these casesmay reveal subtle wall thickening that will help establish the
stomach as the origin of the mass (17).
A peripheral enhancement pattern was present in the
majority (75%) of our cases on intravenous contrast-enhanced
CT images (Fig. 3) whereas homogeneous enhancement, in
small sized cases, presented in a minority (25%) of cases
(Fig. 2).
Correlation of this appearance with gross pathologic ﬁnd-
ings demonstrates that this pattern represents enhancement
of peripheral areas of viable tumor. Central areas of low atten-
uation correspond to hemorrhage, necrosis, or cyst formation.
Lesions with extensive hemorrhage or necrosis may form
large cystic spaces or cavities. The cavities may communicate
with the gastric lumen and contain air, air-ﬂuid levels, or oral
contrast media (19).
Calciﬁcation is an unusual feature of GISTs, seen in only
one (3%) of our gastric cases. It may occur in a mottled pat-
tern or be present extensively throughout the tumor. CT may
also demonstrate evidence of adjacent organ invasion, ascites,
omental and peritoneal spread of tumor, or liver metastasis.
Metastatic lymphadenopathy is not a feature in patients with
GISTs. None of our cases presented with focal or multicentric
calciﬁcation (20).
The differential diagnosis (18) for gastric GISTs includes
other neoplastic growths from gastric wall which simulate
Figure 3 Male patient 52 years presented with epigastric swell-
ing. Contrast enhanced axial serial scan of large centrally necrotic
gastric GIST from antero-medial aspect of gastric body of mainly
exophytic component with broad attachment to the lesser curva-
ture of the stomach, exerting mass effect upon gastric lumen.
Marginal enhancement of rim of soft tissue and non enhancing
large necrotic central portion.
Figure 4 Female patient 45 years presented with excessive
vomiting and epigastric pain. A and B revealed serial MDCT
cuts of large totally exophytic pathologically proved malignant
gastric GIST from postero-lateral wall of the gastric fundus and
body, along the greater curvature showed poorly enhancing mass
compressing the gastric lumen markedly with heterogeneous non
enhancing low attenuation areas due to necrotic nature of the
exophytic component.
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plasms such as true leiomyomas, leiomyosarcomas, schwanno-
mas, neuroﬁbromas, and neuroendocrine neoplasms (e.g.,
solitary gastric carcinoids). Solitary gastric carcinoids are most
commonly seen in the antrum and characteristically have a
central ulceration.
Other common neoplastic growths include gastric adeno-
carcinoma and lymphoma rarely demonstrate marked
exophytic growth. However, they may occasionally have a
radiologic appearance similar to that of GISTs––that is, a
predominantly mural location or an intraluminal component.
Advanced gastric carcinomas and lymphomas commonly
have associated perigastric, hepatoduodenal ligament, and ce-
liac lymphadenopathy, which are not seen in malignant GISTs
and are considered as a respectable differentiating point.
Lymphoma may be associated with bulky adenopathy or
adenopathy that extends into the lower abdomen and pelvis.
Adenopathy is not usually observed in cases of gastric GISTs.
5.2. Small intestine
GISTs may occur throughout the small intestine. Of the eight
small intestinal GISTs in our series, three were located in the
duodenum, three in the jejunum, and two in the ileum. The tu-
mors ranged from 2.2 to 16 cm in maximal dimension, with a
mean size of 8.6 cm.
Regarding the behavior of intestinal GIST, like gastric
GISTs, many intestinal tumors often have an extra-serosal
component. These tumors may exhibit signiﬁcant mass effect
on the affected segment of intestine or adjacent segments.
Cavity and ﬁstula formation may occur, but less frequently,
resulting in luminal enlargement and communication of the
cavity or ﬁstula with the intestinal lumen (21).
Mass effect on surrounding structures with large masses is
also noted as for example obstructive jaundice with a case of
gastric GIST compressing CBD (Fig. 5).
The intraluminal, mural, and extra-serosal components of
small intestinal GISTs are well depicted on MDCT images.
GISTs may appear as an intramural mass or intraluminalpolyp. Three cases (33%) of the small intestinal GISTs in
our series were primarily in an extra-serosal location such that
a small bowel origin was not readily evident at CT.
Following intravenous administration of contrast media,
GISTs are typically enhancing masses with areas of low atten-
uation from hemorrhage, necrosis, or cyst formation (22). A
homogeneous pattern of attenuation is less common and was
present in two of our cases (Fig. 7).
Vascular supply of the lesion as well as the course of vascu-
lar pedicle easily demonstrated with CT angiography, MIP
(maximum intensity projection) as well as CPR (curved plan-
ner reconstruction) of the arterial supply (Fig. 6).
Extension into the adjacent small bowel mesentery and
encasement of noncontiguous segments of small intestine, co-
lon, bladder, ureter, and abdominal wall may occur (22). Pa-
tients with malignant GISTs may present with metastases to
the liver, omentum, and peritoneum (23,24).
In those patients who presented with signs and symptoms
of small intestinal obstruction, abdominal radiography showed
evidence of small intestinal dilatation or a soft-tissue mass.
Irregular gas collections were evident on abdominal radio-
graphs in those patients who had cavitary masses containing
air (25).
Small luminal or mural based GISTs have high mobility
potentials and can be demonstrated in changeable locations
during serial phases or scans (Fig. 8).
The differential diagnosis (25) for small intestinal GISTs
includes primary and metastatic small intestinal neoplasms.
Adenocarcinoma is the most common primary malignancy
of the small bowel. It typically manifests as an annular lesion
in the proximal small intestine; thus, its appearance usually
does not overlap with that of GISTs. However it has many
features similar to those of GIST.
Lymphoma produces large masses within the small intestine
that may ulcerate, cavitate, and extend into the adjacent mes-
entery. In these cases, lymphoma may be indistinguishable
from a GIST on radiologic images. The presence of associated
lymphadenopathy, however, would favor the diagnosis of lym-
phoma (26).
Figure 5 Mass effect as obstructed mid portion of CBD by exophytic gastro-duodenal GIST.
Figure 6 Forty four years old female presenting with obscure GI bleeding. This case highlights the hypervascular nature, with a vascular
pedicle.
Figure 7 Twenty eight years old female presenting with obscure
GI bleeding. This case highlights a duodenal GIST with homog-
enous contrast enhancement.
Figure 8 Forty eight years old female presenting with recurrent abdo
on small bowel GIST’s moving around in the abdomen with their ca
January 2011. (C) April 2011.
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Primary colonic GISTs are much less common than gastric,
small intestinal, and equal in presentation to anorectal and
esophageal GISTs, although GISTs metastatic from other sites
commonly involve the external aspect of the colon. We had
two cases of a colonic GIST in our series, one of them pre-
sented in (Fig. 9). In the literature, they are described as trans-
mural tumors that involve the intraluminal and extraserosal
surfaces of the colon (27).
They may be smooth or multinodular in contour and may
contain central areas of hemorrhage, cystic change, necrosis,
or calciﬁcation. A circumferential growth pattern with aneur-
ismal dilatation of the affected colonic segment has been
observed in a colonic GIST (27).minal colics. This case highlights the characteristic mobile nature
rrying loops. Two small jejunal GIST’s in (A) October 2010. (B)
Figure 9 Fifty nine years female patient with right iliac fossa mass, showed A axial, B coronal and C sagittal images demonstrating a
case of cecal GIST showing mainly exophytic and necrotic nature, bulging within right iliac fossa. Differential diagnosis of abscess versus
GIST was considered and conﬁrmed pathologically to be malignant GIST.
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of colonic GISTs are similar to those of leiomyosarcomas.
Small lesions are typically conﬁned to the wall of the colon
and appear as mural or submucosal masses at barium
examination.
Mucosal ulceration may be present. The lesions in our ser-
ies ranged from 10–18 cm and are seen as large exophytic
masses, with central necrosis, that extended beyond the serosal
surface of the colon on CT images.
The radiologic differential diagnosis for colonic GISTs
includes adenocarcinoma, lymphoma, metastatic melanoma,
and leiomyosarcoma. Retroperitoneal sarcomas such as malig-
nant ﬁbrous histiocytoma, ﬁbrosarcoma, and liposarcoma
arising adjacent to the colon may appear to have a colonic ori-
gin and may also be confused with a GIST (19).
6. Anorectum
Focal well-circumscribed mural mass is the most common
ﬁnding on CT and MRI images. Unfortunately, the only case
we met during this study for anorectal GIST had MRI and not
CT study.
Mucosal ulceration may be present. External spread fre-
quently occurs with extension of the mass into the ischiorectal
fossa, prostate, or vagina.
The least common appearance is a focal intraluminal poly-
poidmass. The CT attenuation of anorectal GISTs is similar to
that of GISTs in other locations of the gastrointestinal tract.
Low-attenuation areas of hemorrhage are commonly present
(28).
On T1-weighted MR images, anorectal GISTs have uni-
form, intermediate signal intensity; on T2-weighted images
they have heterogeneous high signal intensity, with heteroge-
neous enhancement following gadolinium administration
(Fig. 10).
The differential diagnosis for anorectal GISTs includes
both epithelial and nonepithelial neoplasms of the anorectal
region. Rectal adenocarcinoma, anal squamous cell carci-
noma, lymphoma, malignant melanoma, carcinoid, leiomy-
oma, and leiomyosarcoma may have imaging appearances
similar to that of GISTs, although leiomyosarcoma may have
a dominant polypoid intraluminal component (27,28).Carcinomas tend to have irregular margins and may be
associated with perirectal lymphadenopathy, whereas GISTs
tend to have well-deﬁned margins and lack perirectal adenop-
athy (29).
GISTs that have signiﬁcant perirectal extension may be
mistaken as tumors arising from adjacent structures such as
prostatic adenocarcinoma or sarcomas of the prostate and per-
ineum. Anorectal lymphoma is seen in patients with AIDS
(acquired immunodeﬁciency syndrome) and manifests radio-
graphically as an eccentric or annular mural mass that may
be associated with mucosal ulceration or perianal ﬁstulization
(29).
7. Mesentery and omentum
Primary GISTs may occur in any of the mesenteric or omental
structures within the peritoneum. We had one case in our series
measuring 8 · 10 cm (Fig. 11). In the series reported by Miet-
tinen et al. (6), the median size of primary omental and mesen-
teric GISTs was 16.5 cm.
The presence of hemorrhage, necrosis, and cystic change in
these tumors results in the appearance of a complex mass on
cross-sectional images. The cystic component of the tumor
may be the dominant feature. The peripheral solid portions
of the tumor enhance during intravenous contrast material
administration (1).
The only case in our study presents the typical features of
pre-sacral centrally necrotic mass with mildly enhancing
peripheral solid component, having lobulated well deﬁned out-
er margins and proved pathologically to be mesenteric GIST.
The imaging appearance of mesenteric and omental GISTs
is indistinguishable from those of other sarcomas that may
arise in these locations, such as leiomyosarcoma, malignant ﬁ-
brous histiocytoma, ﬁbrosarcoma, and liposarcoma (18).
GISTs from the gastrointestinal tract may metastasize to
the omentum and mesentery; however, they typically result
in multiple masses throughout the peritoneal cavity. In these
instances, the differential diagnosis includes peritoneal carci-
nomatosis, lymphomatosis, and the benign condition leiomyo-
matosis peritonealis disseminata; the latter typically manifests
as innumerable small nodules measuring only a few millimeters
each (18,19).
Figure 10 Sixty years old male presenting with fresh bleeding per rectum, and palpable PR mass. (A) axial T1 (B) axial T2, (C) Sagittal
T2 and (D) T1 fat sat Gado. Demonstrate anorectal exophytic GIST with inhomogeneous enhancement.
Figure 11 Male patient 67 years presented with accidentally
discovered pelvic mass noted during MRI lumbar spines exami-
nation. Axial contrast enhanced CT scan revealed large sized
necrotic pelvic mass lesion displacing bowel loops laterally with
the enhancing vessels seen passing on outer surface without
obstruction. Stellate shape central non enhancing necrosis with
mildly enhancing peripheral rim of soft tissue. First diagnosis to be
retroperitoneal sarcoma and proved pathologically be mesenteric
GIST.
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Esophageal GISTs are relatively uncommon, and we had no
cases of an esophageal GIST in our series. GISTs accounted
for approximately 25% of esophageal mesenchymal neoplasms
studied by Miettinen et al (6).
In contrast, leiomyomas are the most common mesenchy-
mal neoplasm of the esophagus (75% of cases) and occur in
a younger population (median age, 35 years) compared with
GISTs (for whom the median patient age is 63 years) (6).Esophageal GISTs are reported to range up to 25 cm in size
and are most commonly located in the distal third of the
esophagus (30,31). Small lesions tend more to be esophageal
polyps than GIST.
Barium studies of the esophagus may show a smooth intra-
mural mass or a large, ulcerative mass that extends into the
esophageal lumen. Distal lesions may extend into the proximal
stomach. On CT images, these lesions may be homogeneous or
heterogeneous in attenuation. They may contain central areas
of low attenuation from hemorrhage, necrosis, or cystic degen-
eration (30).
The use of endoluminal ultrasonography with ﬁne-needle
aspiration biopsy has been reported as a useful technique to
aid in characterization, diagnosis, and management of submu-
cosal lesions of the esophagus (32).
Papilloma, adenoma, inﬂammatory polyp, ﬁbrovascular
polyp, and esophageal carcinoma manifest as intraluminal pol-
ypoid masses and are considered in the differential diagnosis
(30).
9. Conclusions
GISTs most commonly involve the muscularis propria of the
stomach or intestinal wall and extend to involve extramural,
mural, and intraluminal surfaces of the stomach and intestine.
The extramural component of GISTs may be extensive such
that the bulk of the tumor is outside the organ of origin.
GISTs occurring in the gastrointestinal tract and mesentery
characteristically have hemorrhage, necrosis, or cyst formation
that appears as focal areas of low attenuation on CT images.
Although the radiologic features of GISTs are often distinct
146 A.H. Aﬁﬁ, M. Eidfrom those of epithelial tumors, criteria to separate GISTs
radiologically from other nonepithelial tumors have not yet
been fully developed.
Multislice CT with its multiplanar capabilities and isotropic
z-axis resolution allows the radiologist to examine the detailed
relation of the mass to the surrounding bowel wall, vessels and
other structures. It also helps to map the vascular pedicle in
cases of hypervascular GIST’s, which may be crucial for
trans-catheter embolization in cases presenting with acute
gastrointestinal bleeding.
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